These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1628125)

  • 1. The role of recombinant cytokines and other immunomodulators on engraftment following allogeneic bone marrow transplantation in mice.
    Bieder A; Weiss L; Slavin S
    Bone Marrow Transplant; 1992 Jun; 9(6):421-6. PubMed ID: 1628125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2 activated cell-mediated immunotherapy: control of minimal residual disease in malignant disorders by allogeneic lymphocytes and IL-2.
    Slavin S; Ackerstein A; Kedar E; Weiss L
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():86-90. PubMed ID: 2390644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of delayed sequential bone marrow transplantation on acute graft-versus-host disease in major H-2 incompatible mouse transplantation].
    Wang CL; Xu KL; Pan XY; Du B
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):92-6. PubMed ID: 18681308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
    J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo cytokine-induced facilitation of immunohematopoietic reconstitution in mice undergoing bone marrow transplantation.
    Kedar E; Tsuberi BZ; Landesberg A; Anafi M; Leshem B; Gillis S; Urdal DL; Slavin S
    Bone Marrow Transplant; 1988 Jul; 3(4):297-314. PubMed ID: 3048495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
    Soderling CC; Song CW; Blazar BR; Vallera DA
    J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice.
    Down JD; Westerhof GR; Boudewijn A; Setroikromo R; Ploemacher RE
    Bone Marrow Transplant; 1998 Feb; 21(4):327-30. PubMed ID: 9509964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B; Li DP; Xu KL; Pan XY
    Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment.
    Gammie JS; Li S; Colson YL; Demetris AJ; Neipp M; Ildstad ST; Pham SM
    Exp Hematol; 1998 Sep; 26(10):927-35. PubMed ID: 9728927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
    Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyclosporine A and methylprednisolone on the graft-versus-leukemia effects across major histocompatibility barriers in mice following allogeneic bone marrow transplantation.
    Weiss L; Reich S; Slavin S
    Bone Marrow Transplant; 1990 Oct; 6(4):229-33. PubMed ID: 2085696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
    Down JD; Ploemacher RE
    Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation: effects of marrow dose.
    Koh CY; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2005 Apr; 11(4):252-9. PubMed ID: 15812390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice.
    Cui YZ; Hisha H; Yang GX; Fan TX; Jin T; Li Q; Lian Z; Ikehara S
    Bone Marrow Transplant; 2002 Dec; 30(12):843-9. PubMed ID: 12476275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study on NK cells promoting donor marrow engraftment and hematopoietic reconstitution after MHC haploidentical BMT in mice].
    Wang CY; Guo KY; Wu BY; Wu LX; Jiang ZY; Pan XH
    Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):290-2. PubMed ID: 15182539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
    Weiss L; Reich S; Slavin S
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):145-52. PubMed ID: 10641572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on graft-versus-leukemia effects of donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation].
    Du B; Li D; Xu K
    Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):403-7. PubMed ID: 11718089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.
    Elkin G; Prigozhina TB; Slavin S
    Exp Hematol; 2004 Jun; 32(6):579-84. PubMed ID: 15183899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of Ly5 (CD45)-antigens hampers long-term engraftment following minimal conditioning in a murine bone marrow transplantation model.
    van Os R; Sheridan TM; Robinson S; Drukteinis D; Ferrara JL; Mauch PM
    Stem Cells; 2001; 19(1):80-7. PubMed ID: 11209093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.